Contents: Volume 4 – Part 2 Translational Medicine in CVD

Larry H Bernstein, MD, FCAP

http;//larryhdotme/ 4_Part 2_Translational_ Medicine_in_CVD

About larryhbern

I currently have been engaged engaged with a medical informatics project called "Second Opinion" with Gil David and Prof. Ronald Coifman in the Program in Applied Mathematics at Yale. We plan a proof of concept study. I was the Chief, Clinical Pathology at NY Methodist Hospital, a 600+ bed hospital in Park Slope, Brooklyn, 2 hours from Bridgeport, CT, where I worked for 5 years, and was previously Chief of Clinical Chemistry and Chief of Blood Bank at Bridgeport Hospital for 22 years, and Acting Chairman of Yale University Department of Pathology at Bridgeport Hospital for one year prior to my experience at NY Methodist Hospital Weill-Cornell. I have done extensive work with nutrition (co-chaired the First International Transthyretin Congress in Strasbourg, chaired the 14th Ross Roundtable in Nutrition and the Beckman Roundtable on Prealbumin, and was recipient of the Labbe/Garry award of the Nutrition Division of AACC), troponins and with NT-proBNP and have current projects in normalizing the NT-proBNP for age and estimated glomerular filtration rate, with good success. I have served on the Board of Directors of NAACLS and the American Library Association Commission on Accreditation, am listed in America’s Top Physicians, Marquis Who’s Who in Science and Engineering and Marquis’ Who’s Who in Medicine.
This entry was posted in cardiovascular diseases, endothelium, gene expression, hypertension, nitric oxide, nutritional factors, proteomics, PTMs, translational medicine, type 2 diabetes and tagged , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s